Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-30

FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LOXAPINE (loxapine) from Actavis Pharma, Inc., under an ANDA submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOXAPINE (loxapine)

Snippet

SUPPL AP for LOXAPINE (LOXAPINE)